Digital radiography (mammography) detects as many breast cancers as screen film mammography and more cancers than computed radiography.
Digital direct radiography (DR) detects more breast cancers than does computed radiography (CR), according to a study published in the journal Radiology.
Researchers from Prevention and Cancer Control at Cancer Care Ontario in Toronto, Canada, compared findings from DR, MR, and screen film mammography to assess their comparative effectiveness in breast cancer screening.
Anna M. Chiarelli, PhD, and her colleagues accessed the mammographies of 403,688 women in Ontario who had been screened between January 1, 2008, and December 31, 2009. Of these women, 220,520 underwent DR and 64,210 underwent CR. The rest underwent screen film mammography. The women were followed for 12 months following their screening.
The researchers found that DR detected 4.9 cancers per 1,000 mammograms, similar to screen film mammography findings, 4.8 per 1,000. Computed radiography only detected 3.4 cancers per 1,000 mammograms.
“CR was 21 percent less effective than DR,” Chiarelli said in a release. “This could result in about 10 fewer cancers detected per 10,000 women screened.”
Technical factors could account for some of the lower detection rates, the authors wrote; DR takes an electronic image of the breast that can be stored and sent electronically, while CR is an offline system. There could be a loss of spatial resolution or sharpness, or there could be increased image noise or granularity, Chiarelli noted.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.